Dr Brent Muir Roster, MD | |
2360 Mullan Rd Ste C, Missoula, MT 59808-1811 | |
(406) 721-4436 | |
(406) 721-6053 |
Full Name | Dr Brent Muir Roster |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 15 Years |
Location | 2360 Mullan Rd Ste C, Missoula, Montana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720222508 | NPI | - | NPPES |
1720222508 | Medicaid | NV |
Facility Name | Location | Facility Type |
---|---|---|
St. Patrick Hospital | Missoula, MT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Missoula Bone And Joint, Llc | 3870583990 | 46 |
News Archive
Following an audit last year by the Global Fund to Fight AIDS, Tuberculosis and Malaria that found Papua New Guinea's National Department of Health (NDOH) "had not complied with grant guidelines and some $7 million had been misdirected," the government is stepping down as the principal recipient (PR) of Global Fund grants in order to "improve its response," IRIN reports.
NormOxys Inc., a biotechnology company developing a novel class of small molecule drugs which enhance the body's ability to deliver oxygen to diseased tissues and organs, today announced that OXY111A, its clinical stage candidate for the treatment of chronic heart failure and cancer, has been selected as one of Windover's "Top 10 Cardiovascular/Metabolic Projects to Watch."
Alexion Pharmaceuticals, Inc. today announced the presentation of final data from the two Phase 2 studies of Soliris as a treatment for patients with atypical hemolytic uremic syndrome.
This month's issue of Cold Spring Harbor Protocols features two articles detailing experimental methods for the analysis of molecular processes involved in DNA repair and post-translational modification of proteins.
› Verified 9 days ago
Entity Name | Missoula Bone & Joint, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1447207212 PECOS PAC ID: 3870583990 Enrollment ID: O20040512001126 |
News Archive
Following an audit last year by the Global Fund to Fight AIDS, Tuberculosis and Malaria that found Papua New Guinea's National Department of Health (NDOH) "had not complied with grant guidelines and some $7 million had been misdirected," the government is stepping down as the principal recipient (PR) of Global Fund grants in order to "improve its response," IRIN reports.
NormOxys Inc., a biotechnology company developing a novel class of small molecule drugs which enhance the body's ability to deliver oxygen to diseased tissues and organs, today announced that OXY111A, its clinical stage candidate for the treatment of chronic heart failure and cancer, has been selected as one of Windover's "Top 10 Cardiovascular/Metabolic Projects to Watch."
Alexion Pharmaceuticals, Inc. today announced the presentation of final data from the two Phase 2 studies of Soliris as a treatment for patients with atypical hemolytic uremic syndrome.
This month's issue of Cold Spring Harbor Protocols features two articles detailing experimental methods for the analysis of molecular processes involved in DNA repair and post-translational modification of proteins.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Brent Muir Roster, MD 2360 Mullan Rd, Ste C, Missoula, MT 59808-1811 Ph: (406) 721-4436 | Dr Brent Muir Roster, MD 2360 Mullan Rd Ste C, Missoula, MT 59808-1811 Ph: (406) 721-4436 |
News Archive
Following an audit last year by the Global Fund to Fight AIDS, Tuberculosis and Malaria that found Papua New Guinea's National Department of Health (NDOH) "had not complied with grant guidelines and some $7 million had been misdirected," the government is stepping down as the principal recipient (PR) of Global Fund grants in order to "improve its response," IRIN reports.
NormOxys Inc., a biotechnology company developing a novel class of small molecule drugs which enhance the body's ability to deliver oxygen to diseased tissues and organs, today announced that OXY111A, its clinical stage candidate for the treatment of chronic heart failure and cancer, has been selected as one of Windover's "Top 10 Cardiovascular/Metabolic Projects to Watch."
Alexion Pharmaceuticals, Inc. today announced the presentation of final data from the two Phase 2 studies of Soliris as a treatment for patients with atypical hemolytic uremic syndrome.
This month's issue of Cold Spring Harbor Protocols features two articles detailing experimental methods for the analysis of molecular processes involved in DNA repair and post-translational modification of proteins.
› Verified 9 days ago
Taylor Buckley, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2740 South Ave W Ste 101, Missoula, MT 59804 Phone: 406-728-6101 Fax: 406-721-3278 | |
Dr. Stephen George Powell, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2831 Fort Missoula Rd, Suite 232, Missoula, MT 59804 Phone: 406-728-6101 Fax: 406-721-3278 | |
Dr. James Joseph Gholson, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2360 Mullan Rd Ste C, Missoula, MT 59808 Phone: 406-721-4436 Fax: 406-721-6053 | |
Joseph Fox, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2835 Fort Missoula Rd Ste 201, Missoula, MT 59804 Phone: 406-327-4730 | |
Paul Andrew Puckett, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2360 Mullan Rd, Suite C, Missoula, MT 59808 Phone: 406-721-4436 Fax: 406-721-6053 | |
Dr. Larry R. Stayner, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2740 South Ave W Ste 101, Missoula, MT 59804 Phone: 406-728-6101 Fax: 406-721-3278 | |
Dr. Zackery W Witte, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2360 Mullan Rd Ste C, Missoula, MT 59808 Phone: 406-721-4436 Fax: 406-721-6053 |